英科醫療(300677.SZ):湖南英科醫療完成設立登記並取得營業執照
格隆匯 9 月 4日丨英科醫療(300677.SZ)公佈,公司於2020年9月2日召開第二屆董事會第三十七次會議,審議通過了《關於在臨湘市設立全資子公司實施年產400億隻(4000萬箱)高端醫用手套項目和控股子公司實施城陵磯新港區北片區(臨湘工業園)熱電聯產項目的議案》。
近日,公司收到全資子公司設立登記完成的通知,並取得了主管部門頒發的《營業執照》,名稱為湖南英科醫療科技有限公司。
經營範圍:丁腈手套、乳膠手套、PVC手套、PE手套(不含危險化學品及一類易製毒化學品)的生產、銷售,PVC粉、橡膠製品、塑膠製品、化工產品(不含危險化學品及一類易製毒化學品)、煤炭的銷售,貨物進出口(國家禁止或涉及行政審批的貨物進出口除外)。(依法須經批准的項目,經相關部門批准後方可開展經營活動)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.